WallStreetZenWallStreetZen

NASDAQ: ANTX
An2 Therapeutics Inc Stock

$9.87+0.24 (+2.49%)
Updated Mar 31, 2023
ANTX Price
$9.87
Fair Value Price
N/A
Market Cap
$191.50M
52 Week Low
$6.88
52 Week High
$23.58
P/E
-3.54x
P/B
2.01x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$40.96M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.08
Operating Cash Flow
-$33M
Beta
1.01
Next Earnings
May 10, 2023
Ex-Dividend
N/A
Next Dividend
N/A

ANTX Overview

AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develop treatments for rare, chronic, and infectious diseases. It is developing epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial lung disease. The company uses boron chemistry for its research and development initiatives. AN2 was incorporated in 2017 and is headquartered in Menlo Park, CA.

Zen Score

Industry Average (25)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how ANTX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

ANTX is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
ANTX is good value based on its book value relative to its share price (2.01x), compared to the US Biotechnology industry average (4.98x)
P/B vs Industry Valuation
ANTX is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more ANTX due diligence checks available for Premium users.

Be the first to know about important ANTX news, forecast changes, insider trades & much more!

ANTX News

Valuation

ANTX fair value

Fair Value of ANTX stock based on Discounted Cash Flow (DCF)
Price
$9.87
Fair Value
$11.04
Undervalued by
10.59%
ANTX is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

ANTX price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-3.54x
Industry
18.64x
Market
22.13x

ANTX price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
2.01x
Industry
4.98x
ANTX is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

ANTX's financial health

Profit margin

Revenue
$0.0
Net Income
-$11.8M
Profit Margin
0%
ANTX's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$102.6M
Liabilities
$7.2M
Debt to equity
0.08
ANTX's short-term assets ($98.62M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ANTX's short-term assets ($98.62M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ANTX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$7.6M
Investing
$6.1M
Financing
$0.0
ANTX's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

ANTX vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
ANTX$191.50M+2.49%-3.54x2.01x
TNYA$190.57M+6.34%-1.03x0.78x
ZVRA$189.97M+0.27%-4.58x2.21x
OCGN$193.13M+3.52%-2.24x2.30x
NVCT$193.40M+5.47%-8.68x13.60x

An2 Therapeutics Stock FAQ

What is An2 Therapeutics's quote symbol?

NASDAQ: ANTX) An2 Therapeutics trades on the NASDAQ under the ticker symbol ANTX. An2 Therapeutics stock quotes can also be displayed as NASDAQ: ANTX.

If you're new to stock investing, here's how to buy An2 Therapeutics stock.

What is the 52 week high and low for An2 Therapeutics (NASDAQ: ANTX)?

(NASDAQ: ANTX) An2 Therapeutics's 52-week high was $23.58, and its 52-week low was $6.88. It is currently -58.14% from its 52-week high and 43.48% from its 52-week low.

How much is An2 Therapeutics stock worth today?

(NASDAQ: ANTX) An2 Therapeutics currently has 19,402,658 outstanding shares. With An2 Therapeutics stock trading at $9.87 per share, the total value of An2 Therapeutics stock (market capitalization) is $191.50M.

An2 Therapeutics stock was originally listed at a price of $15.40 in Mar 25, 2022. If you had invested in An2 Therapeutics stock at $15.40, your return over the last 1 years would have been -35.91%, for an annualized return of -35.91% (not including any dividends or dividend reinvestments).

How much is An2 Therapeutics's stock price per share?

(NASDAQ: ANTX) An2 Therapeutics stock price per share is $9.87 today (as of Mar 31, 2023).

What is An2 Therapeutics's Market Cap?

(NASDAQ: ANTX) An2 Therapeutics's market cap is $191.50M, as of Apr 2, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

An2 Therapeutics's market cap is calculated by multiplying ANTX's current stock price of $9.87 by ANTX's total outstanding shares of 19,402,658.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.